Govt may review pharma, housing FDI policies today
29 Nov 2013 5:14 AM IST
The Cabinet is likely to take a decision on Thursday on relaxing FDI norms for the housing sector and reducing foreign investment limit to 49 per cent in rare and critical areas of the pharma segment.
'All the three issues are there in the Cabinet's agenda, an official said.
On FDI in pharmaceuticals, several departments, including the DIPP, have raised serious concerns over continuous acquisitions of Indian drug makers by global multinational firms. The Department of Industrial Policy and Promotion (DIPP) has proposed to reduce FDI cap from 100 per cent to 49 per cent in the ‘rare or critical pharma verticals’.
According to sources, three categories have been proposed to define ‘rare or critical’.
'All the three issues are there in the Cabinet's agenda, an official said.
On FDI in pharmaceuticals, several departments, including the DIPP, have raised serious concerns over continuous acquisitions of Indian drug makers by global multinational firms. The Department of Industrial Policy and Promotion (DIPP) has proposed to reduce FDI cap from 100 per cent to 49 per cent in the ‘rare or critical pharma verticals’.
According to sources, three categories have been proposed to define ‘rare or critical’.
Next Story
